Annual financial news and ad hoc releases

Annual financial news and ad hoc releases

30July

2021

The demand for non-corona-induced medical and therapeutic measures has been increasing since mid-2021

11June

2021

12:40 pm: Ad hoc-Publication of inside information in acc. with Article 17 of Regulation (EU) No 596/2014: Changes in the Management Board of MEDICLIN Aktiengesellschaft

11June

2021

Dr. Joachim Ramming becomes the new CEO of MEDICLIN

28May

2021

MEDICLIN focuses on patient safety and innovative concepts in rehabilitation

03May

2021

The effects of the coronavirus pandemic are burdening the business development in the first quarter of 2021

26March

2021

MEDICLIN AG: Massive loss of earnings due to corona pandemic – outlook 2021 afflicted with uncertainties – effective protective shield is necessary.

26February

2021

MEDICLIN has achieved the revised targets for 2020

12January

2021

The Board of Management of MEDICLIN will be expanded − Dr. York Dhein will join on April 1st, 2021

03November

2020

3 pm: Ad hoc-Release Disclosure of an inside information acc. to Article17 MAR of the Regulation (EU) No 596/2014: MEDICLIN publishes forecast for fiscal year 2020

31July

2020

Corona-related precautious free capacities reserved as a precaution in the second quarter of 2020 led to a decline in sales and earnings in the Group - a reliable forecast for the 2020 financial year is not yet possible